News
Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...
Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...
Pfizer's forward dividend yield currently stands at 6.86%. This yield is so attractive that I wondered if it's the highest of ...
The American Academy of Pediatrics released its vaccine schedule on Aug 19, which differs from the guidance provided by federal officials.
16h
TipRanks on MSNWhy Pfizer’s (PFE) Oncology Gamble is Finally Paying Off
Pfizer ($PFE) may finally be turning the corner on its post-pandemic revenue challenges. The company recently reported ...
After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...
The American Academy of Pediatrics breaks with federal guidance, urging COVID shots for young kids as Kennedy's panel delays ...
Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...
The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.
BBIO's Acoramidis shows promise but faces tough competition. Diverse pipeline & catalysts ahead, but valuation relies on ...
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...
One of the highest yields you can get right now is from Pfizer (NYSE: PFE). The healthcare giant offers a yield of 6.8%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results